Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2021-05-12 AGM Information
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
Final - Notulen van de Algemene Vergadering 29 April 2021 - NL.pdf
AGM Information Classification · 100% confidence The document is explicitly titled "NOTULEN" (Minutes) of the "GEWONE ALGEMENE VERGADERING VAN AANDEELHOUDERS GEHOUDEN OP DE ZETEL OP DONDERDAG 29 APRIL 2021" (Ordinary General Meeting of Shareholders held at the registered office on Thursday, April 29, 2021). The content details the opening, verification of quorum, the agenda items (including approval of the 2020 annual accounts, remuneration report, and appointment/re-election of directors), and the formal proceedings of the meeting. This directly corresponds to the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting.
2021-05-12 Dutch
20210506 Disposal of own shares.pdf
Transaction in Own Shares Classification · 99% confidence The document is explicitly titled 'Disposals of own shares' and details transactions where UCB disposed of its own shares following stock option exercises and within the framework of its Long Term Incentive Program and Stock Award Plan. This directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance). The document is short and contains specific transaction details, confirming it is the primary report of the activity, not just an announcement of a report. Therefore, the classification is POS.
2021-05-05 English
20210505 Aliénation d'actions propres.pdf
Transaction in Own Shares Classification · 99% confidence The document title is "Aliénation d'actions propres" (Alienation of own shares) and the content details transactions where UCB SA alienated (sold/transferred) its own shares following the exercise of stock options by employees, as well as a free share delivery under a Stock Award Plan. This activity directly corresponds to the definition of a company reporting transactions involving its own shares, which is classified as 'Transaction in Own Shares' (POS). The document is a regulatory announcement dated May 5, 2021, detailing these specific share movements.
2021-05-05 French
20210505 Vervreemding van eigen aandelen.pdf
Transaction in Own Shares Classification · 99% confidence The document title is "Vervreemding van eigen aandelen" (Disposal of own shares). The text details transactions where UCB shares were disposed of (delivered) to employees as part of long-term incentive plans (stock options and stock awards). This activity directly relates to the company buying back or issuing its own shares, specifically in the context of employee compensation plans. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS). The document is a formal announcement of these transactions, not a general regulatory filing (RNS) or a report publication announcement (RPA), as it contains the specific transaction details.
2021-05-05 Dutch
20210429 Results AGM UCB SA 2021.pdf
AGM Information Classification · 99% confidence The document explicitly states it is about 'UCB's General Meeting of Shareholders 2021' and details the outcomes of votes on the agenda, including dividend approval and changes to the Board composition. This directly corresponds to the purpose of an Annual General Meeting (AGM) material. Although it mentions the Integrated Annual Report 2020, the primary focus and context of the release is the meeting itself and its resolutions. Therefore, the most appropriate classification is AGM Information (AGM-R).
2021-04-29 English
20210429 Resultats AGO UCB SA 2021.pdf
AGM Information Classification · 99% confidence The document is titled "Assemblée Générale des Actionnaires d'UCB 2021" (UCB Shareholders' General Meeting 2021) and explicitly states that the Annual General Meeting (AGA) was held virtually. It details key outcomes such as dividend approval (€ 1.27 per share), approval of all agenda items, and significant changes to the Board of Directors (appointment of new members, succession of the Chairman). This content directly relates to the proceedings and outcomes of the Annual General Meeting. Therefore, the appropriate classification is AGM Information (AGM-R). The document is a summary/press release about the meeting, not just a voting result announcement (DVA) or a general regulatory filing (RNS).
2021-04-29 French

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.